Covered recipient · General Payments record
MICHAEL P BRISSON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023
$173.51
- Reported across 10 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $173.51 | 10 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $98.78 | 5 |
| IDORSIA PHARMACEUTICALS US INC | $47.69 | 3 |
| Amgen Inc. | $14.15 | 1 |
| Lilly USA, LLC | $12.89 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2023 | $173.51 | 10 |
Payment records · PY2023 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $14.15 | 02/01/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1020027911 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $13.71 | 03/09/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1034434541 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $19.08 | 06/27/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1034434547 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $14.90 | 11/01/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1034434553 | CMS |
| Lilly USA, LLC | $12.89 | 04/17/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1031963639 | CMS |
| Novo Nordisk Inc | $20.39 | 02/15/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1003003527 | CMS |
| Novo Nordisk Inc | $13.00 | 03/08/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1003003505 | CMS |
| Novo Nordisk Inc | $23.99 | 05/10/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1003003551 | CMS |
| Novo Nordisk Inc | $21.40 | 08/16/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1003003539 | CMS |
| Novo Nordisk Inc | $20.00 | 11/09/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1003003517 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2023
- Source files
- Dataset page · Bulk file · PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.